BioRestorative Therapies (BRTX) Inventory Average (2013 - 2015)
BioRestorative Therapies' (BRTX) quarterly Inventory Average came in at $2492.0 in Q3 2015, down 85.83% YoY from $17587.5 in Q3 2014, and up 12.79% on a QoQ basis from $2209.5 in Q2 2015.
BioRestorative Therapies (BRTX) Inventory Average (2013 - 2015) Analysis & Trends
BioRestorative Therapies (BRTX) has 3 years of Inventory Average data on file, last reported at $2492.0 in Q3 2015.
- Quarterly Inventory Average fell 85.83% year-over-year to $2492.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $2492.0 (down 85.83% YoY) and the FY2014 annual result came in at $9955.0, down 34.61% from the prior year.
- Inventory Average climbed to $2492.0 in Q3 2015, from $2209.5 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $17965.0 in Q4 2013 to a low of $1936.0 in Q1 2015.
- A 3-year average of $11860.8 and a median of $13804.0 in 2013 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2014 — Inventory Average jumped 36.35% — and 2015, when it sank 89.21%.
- Tracing BRTX's Inventory Average over 3 years: stood at $17965.0 in 2013, then sank by 46.2% to $9665.0 in 2014, then tumbled by 74.22% to $2492.0 in 2015.
- The last three Inventory Average figures came in at $2492.0 (Q3 2015), $2209.5 (Q2 2015), and $1936.0 (Q1 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 2,492.00 |
| Jun 30, 2015 | 2,209.50 |
| Mar 31, 2015 | 1,936.00 |
| Dec 31, 2014 | 9,665.00 |
| Sep 30, 2014 | 17,587.50 |
| Jun 30, 2014 | 17,847.00 |
| Mar 31, 2014 | 17,934.50 |
| Dec 31, 2013 | 17,965.00 |
| Sep 30, 2013 | 15,875.50 |
| Jun 30, 2013 | 13,804.00 |
| Mar 31, 2013 | 13,153.00 |